Keybank National Association OH boosted its position in shares of Clorox Co (NYSE:CLX) by 3.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,985 shares of the company’s stock after acquiring an additional 758 shares during the quarter. Keybank National Association OH’s holdings in Clorox were worth $3,491,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Asahi Life Asset Management CO. LTD. bought a new stake in Clorox during the second quarter valued at about $340,000. Cambridge Investment Research Advisors Inc. grew its holdings in Clorox by 3.2% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock valued at $4,196,000 after purchasing an additional 858 shares during the period. Ontario Teachers Pension Plan Board grew its holdings in Clorox by 209.0% during the second quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock valued at $5,795,000 after purchasing an additional 25,599 shares during the period. CWM LLC grew its holdings in Clorox by 75.6% during the second quarter. CWM LLC now owns 92,127 shares of the company’s stock valued at $14,106,000 after purchasing an additional 39,668 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Clorox by 4.2% during the second quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock valued at $148,493,000 after purchasing an additional 39,390 shares during the period. Institutional investors own 78.42% of the company’s stock.
In related news, SVP Michael R. Costello sold 6,997 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the completion of the transaction, the senior vice president now directly owns 29,016 shares of the company’s stock, valued at $4,716,840.96. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Andrew J. Mowery sold 5,648 shares of the stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $146.29, for a total value of $826,245.92. Following the transaction, the senior vice president now directly owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,870 shares of company stock valued at $2,484,000. Corporate insiders own 1.14% of the company’s stock.
Several analysts have issued reports on the company. UBS Group cut their price target on Clorox from $128.00 to $125.00 and set a “sell” rating for the company in a report on Thursday, October 3rd. Royal Bank of Canada boosted their price target on Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. ValuEngine lowered Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Citigroup cut their price target on Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Finally, Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a research note on Monday, July 29th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $152.00.
Shares of NYSE CLX traded up $0.98 during mid-day trading on Friday, reaching $148.00. The company’s stock had a trading volume of 639,305 shares, compared to its average volume of 896,025. The firm has a market capitalization of $18.55 billion, a PE ratio of 23.42, a P/E/G ratio of 4.73 and a beta of 0.38. The company has a debt-to-equity ratio of 4.69, a current ratio of 0.87 and a quick ratio of 0.52. The stock has a fifty day moving average of $149.93 and a two-hundred day moving average of $154.33. Clorox Co has a 52 week low of $143.58 and a 52 week high of $167.70.
Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.05. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.51 billion. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The business’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.62 earnings per share. Analysts anticipate that Clorox Co will post 6.16 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 30th will be paid a $1.06 dividend. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date is Tuesday, October 29th. Clorox’s dividend payout ratio (DPR) is 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: How to identify percentage decliners
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.